CETP and coronary artery disorder: Third, only one promoter polymorphism, C-629A in CETP was meta-analyzed, which is clearly not sufficient to support the contributory role of CETP in the pathogenesis of CHD and lipid regulation, as other polymorphisms in or flanking CETP might synergize or antagonize the impact of C-629A.